DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04651855 (ClinicalTrials.gov)	December 2, 2020	30/9/2020	The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS	The Evaluation of the Effect of Wharton's Jelly Mesenchymal Stem Cells (WJMSCs) on the Immune System of Patients With Amyotrophic Lateral Sclerosis (ALS)	Amyotrophic Lateral Sclerosis	Drug: Mesenchymal stem cells isolated from Wharton's jelly	Polski Bank Komorek Macierzystych JSC (PBKM)	The National Centre for Research and Development	Recruiting	18 Years	N/A	All	20	Phase 1;Phase 2	Poland

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT04651855
(ClinicalTrials.gov)

December 2, 2020

30/9/2020

The Evaluation of the Effect of Mesenchymal Stem Cells on the Immune System of Patients With ALS

The Evaluation of the Effect of Wharton's Jelly Mesenchymal Stem Cells (WJMSCs) on the Immune System of Patients With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

Drug: Mesenchymal stem cells isolated from Wharton's jelly

Polski Bank Komorek Macierzystych JSC (PBKM)

The National Centre for Research and Development

Recruiting

18 Years

N/A

All

Phase 1;Phase 2

Poland